Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· July 15, 2026

Sify reports Consolidated Financial Results for Q1 FY 2026-27

View original at globenewswire.com
Sify reports Consolidated Financial Results for Q1 FY 2026-27 Revenues of INR 12,352 Million. Adjusted EBITDA of INR 3,005 Million. Profit for the period INR 65 Million…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Revenue was INR 12,352 million, an increase of 15% over the same quarter last year.

    60% confidence
  • Adjusted EBITDA was INR 3,005 million, an increase of 42% over the same quarter last year.

    60% confidence
  • The cash balance at the end of the quarter was INR 4,597 million.

    60% confidence
  • India's digital transformation is entering a phase of execution at scale, and Sify's integrated portfolio of Data Centers, Networks, and Digital Services positions it to support customers modernizing for an AI-enabled future.

    60% confidence
  • During the quarter, Sify strengthened the operational foundations of its businesses through disciplined execution, improved resource utilization, and targeted investments, while continuing to invest in capacity expansion, network modernization, and technology platforms for AI, cloud, and data-intensive workloads.

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com
Sify reports Consolidated Financial Results for Q1 FY 2026-27 — Source | Via News | ViaNews Market